Literature DB >> 11310967

Gemini (dimeric) surfactant perturbation of the human erythrocyte.

M Dubnicková1, M Bobrowska-Hägerstrand, T Söderström, A Iglic, H Hägerstrand.   

Abstract

We studied the ability of di-cationic gemini surfactantsdi (amphiphiles), i.e. 1,4-butanediammonium-N,N-dialkyl-N,N,N',N'-tetramethyl bromides (Di-Cm-di-QAS (s = 4), where m = 8, 11, 13, 16 and s = the number of alkyl groups in the spacer) to induce shape alteration, vesiculation, haemolysis and phosphatidylserine exposure in human erythrocytes, and to protect erythrocytes against hypotonic haemolysis. At high sublytic concentrations the Di-Cm-di-QAS (s = 4) amphiphiles rapidly induced echinocytic (spiculated) shapes and a release of exovesicles, mainly in the form of tubes, from the cell surface. Following 60 min incubation erythrocytes were sphero-echinocytic and a few cells with invaginations/endovesicles were observed. No phosphatidylserine exposure was detected. The haemolytic potency increased with an increase of the alkyl chain length. At sublytic concentrations the Di-Cm-di-QAS (s = 4) amphiphiles protected erythrocytes against hypotonic haemolysis. It is suggested that the Di-Cm-di-QAS (s = 4) amphiphiles perturb the membrane in a similar way as single-chain cationic amphiphiles, but that they do not easily translocate to the inner membrane leaflet.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11310967

Source DB:  PubMed          Journal:  Acta Biochim Pol        ISSN: 0001-527X            Impact factor:   2.149


  2 in total

1.  Post-prandial rise of microvesicles in peripheral blood of healthy human donors.

Authors:  Vid Suštar; Apolonija Bedina-Zavec; Roman Stukelj; Mojca Frank; Eva Ogorevc; Rado Janša; Keriya Mam; Peter Veranič; Veronika Kralj-Iglič
Journal:  Lipids Health Dis       Date:  2011-03-21       Impact factor: 3.876

2.  Dicationic alkylammonium bromide gemini surfactants. Membrane perturbation and skin irritation.

Authors:  João A S Almeida; Henrique Faneca; Rui A Carvalho; Eduardo F Marques; Alberto A C C Pais
Journal:  PLoS One       Date:  2011-11-10       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.